Format

Send to

Choose Destination
Influenza Other Respir Viruses. 2015 Jan;9(1):20-31. doi: 10.1111/irv.12293. Epub 2014 Nov 15.

Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management.

Author information

1
WHO Collaborating Centre for Reference and Research on Influenza, VIDRL at the Peter Doherty Institute for Infection and Immunity, Parkville, Vic., Australia; Melbourne School of Population and Global Health, University of Melbourne, Parkville, Vic., Australia.

Abstract

This review highlights the main points which emerged from the presentations and discussions at the 3rd isirv-Antiviral Group Conference - advances in clinical management. The conference covered emerging and potentially pandemic influenza viruses and discussed novel/pre-licensure therapeutics and currently approved antivirals and vaccines for the control of influenza. Current data on approved and novel treatments for non-influenza respiratory viruses such as MERS-CoV, respiratory syncytial virus (RSV) and rhinoviruses and the challenges of treating immunocompromised patients with respiratory infections was highlighted.

KEYWORDS:

Antivirals; clinical management; immunocompromised; influenza; respiratory; treatment

PMID:
25399715
PMCID:
PMC4280814
DOI:
10.1111/irv.12293
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center